{"SPADE_N_15340": {"Sequence Information": {"Peptide Name": "Harzianin HC III", "Sequence": "XNLXPSVXPXLXP", "Sequence Length": 13, "Biological Activity": ["Antiparasitic", "Anticancer"], "Binding Target": "1. Lipid Bilayer", "Source": "1. Trichoderma harzianum", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Leveraging Peptaibol Biosynthetic Promiscuity for Next-Generation Antiplasmodial Therapeutics.", "Pubmed ID": "33565879", "Reference": "J Nat Prod. 2021;84:503-517", "Author": "Lee JW, Collins JE, Wendt KL, Chakrabarti D, Cichewicz RH", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/33565879"}], "SPADE ID": "SPADE_N_15340", "Similar Sequences": [{"SPADE_ID": "SPADE_N_01077", "Similarity": 1.0, "Sequence": "GVIDAAKKVVNVLKNLP"}, {"SPADE_ID": "SPADE_UN_17799", "Similarity": 1.0, "Sequence": "LKQGNHINLPS"}, {"SPADE_ID": "SPADE_UN_18151", "Similarity": 1.0, "Sequence": "VPLPAGGGTV"}], "Hemolytic Activity": "", "Target Organism": "Plasmodium falciparum Dd2(EC50=0.56±0.07µM),Human hepatocellular carcinoma HepG2(EC50=>25µM)"}}}